BioZapetite

BioZapetite delivers orforglipron (6 mg), a first-in-class oral, small-molecule GLP-1 receptor agonist designed for investigational use. Unlike peptide GLP-1 agonists, orforglipron is orally bioavailable without fasting or water restrictions and demonstrates robust pharmacology in glucose and weight regulation.

Together, its mechanisms are designed to:

• Promote glucose disposal & insulin sensitivity
• Drive weight reduction & appetite control
• Improve lipid & cardiometabolic health
• Provide oral dosing convenience
• Exhibit a safety profile consistent with injectable GLP-1 medicines.